Suicide in Urban Natives: Detection and Networks to Combat Events
Launched by UNIVERSITY OF COLORADO, DENVER · Apr 27, 2017
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on finding better ways to prevent suicide among American Indian and Alaska Native (AI/AN) youth. The study will compare two different approaches: one group of young people will receive caring text messages designed to help reduce feelings of sadness and thoughts of self-harm, while the other group will receive standard care, which does not include these supportive messages. The goal is to see if the text messages can help improve emotional well-being, increase social connections, and reduce the risk of suicide.
To participate in this trial, individuals need to be between 16 and 24 years old, identify as American Indian or Alaska Native, and have a mobile phone that can receive texts. They must also be at risk for suicidal thoughts, as determined by a healthcare provider, and be willing to communicate via text. Participants will be contacted regularly to receive messages, and they will be contributing to important research that could help save lives in their communities. It’s crucial to note that individuals who are currently in danger of harming themselves or are under 18 years old cannot participate in this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Self-identify as American Indian or Alaska Native;
- • Screen positive for mild, moderate, or severe risk of suicidality (referred by a clinical provider);
- • Have a text-enabled mobile phone;
- • Willing to be contacted by text;
- • Able to participate voluntarily;
- • Speak and read English;
- • Cognitively able to independently provide written informed consent
- Exclusion Criteria:
- • Under age 18
- • In danger of imminent self-harm;
- • Hospitalized
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Albuquerque, New Mexico, United States
Patients applied
Trial Officials
Spero Manson, PhD
Principal Investigator
University of Colorado, Denver
Dedra Buchwald, MD
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials